STRANDSMART

Diagnostic testing devices, namely, diagnostic kits comprised of a cartridge with microelectrodes therein, each microelectrode having a carbon nanotube film with cancer-specific antibodies or other targeting materials thereon for testing blood samples for detection of cancers, specifically breast cancer, colon cancer, lung cancer, pancreatic cancer and prostate cancer; Diagnostic kits comprised of cartridges with microelectrodes therein, each microelectrode having a carbon nanotube film with cancer-specific antibodies or other targeting materials thereon for use with an analysis device for testing of blood for detecting cancers in blood samples, specifically breast cancer, colon cancer, lung cancer, pancreatic cancer and prostate cancer

Medical devices, namely, diagnostic kits consisting primarily of apparatus with microelectrodes therein, each microelectrode having a carbon nanotube film for use with cancer-specific antibodies or other targeting materials thereon, for analyzing blood samples for detecting cancers in blood samples, specifically breast cancer, colon cancer, lung cancer, pancreatic cancer and prostate cancer; Diagnostic testing devices, namely, diagnostic kits comprised of apparatus with microelectrodes therein, each microelectrode having a carbon nanotube film for use with cancer-specific antibodies or other targeting materials thereon, and an analysis device for testing blood samples for detection of cancers, specifically breast cancer, colon cancer, lung cancer, pancreatic cancer and prostate cancer